AAAAAA

   
Results: 1-25 | 26-49
Results: 1-25/49

Authors: TOSS H ERNOFSSON M WALLENTIN L SEIGBAHN A
Citation: H. Toss et al., NO PROGNOSTIC IMPORTANCE OF RESISTANCE TO ACTIVATED PROTEIN-C IN UNSTABLE CORONARY-ARTERY DISEASE DESPITE SIGNS OF THROMBIN ACTIVATION, Journal of thrombosis and thrombolysis, 5(1), 1998, pp. 3-7

Authors: ERNOFSSON M STREKERUD F TOSS H ABILDGAARD U WALLENTIN L SIEGBAHN A
Citation: M. Ernofsson et al., LOW-MOLECULAR-WEIGHT HEPARIN REDUCES THE GENERATION AND ACTIVITY OF THROMBIN IN UNSTABLE CORONARY-ARTERY DISEASE, Thrombosis and haemostasis, 79(3), 1998, pp. 491-494

Authors: LINDAHL B VENGE P WALLENTIN L
Citation: B. Lindahl et al., THE FRISC EXPERIENCE WITH TROPONIN-T - USE AS DECISION TOOL AND COMPARISON WITH OTHER PROGNOSTIC MARKERS, European heart journal, 19, 1998, pp. 51-58

Authors: TOSS H GNARPE J GNARPE H SIEGBAHN A LINDAHL B WALLENTIN L
Citation: H. Toss et al., INCREASED FIBRINOGEN LEVELS ARE ASSOCIATED WITH PERSISTENT CHLAMYDIA-PNEUMONIAE INFECTION IN UNSTABLE CORONARY-ARTERY DISEASE, European heart journal, 19(4), 1998, pp. 570-577

Authors: CAMPBELL RWF WALLENTIN L VERHEUGT FWA TURPIE AGG MASERI A KLEIN W CLELAND JGF BODE C BECKER R ANDERSON J BERTRAND ME CONTI CR
Citation: Rwf. Campbell et al., MANAGEMENT STRATEGIES FOR A BETTER OUTCOME IN UNSTABLE CORONARY-ARTERY DISEASE, Clinical cardiology, 21(5), 1998, pp. 314-322

Authors: DENHEIJER P VERMEER F AMBROSIONI E SADOWSKI Z LOPEZSENDON JL VONESSEN R BEAUFILS P THADANI U ADGEY J PIERARD L BRINKER J DAVIES RF SMALLING RW WALLENTIN L CASPI A PANGERL A TRICKETT L HAUCK C HENRY D CHEW P
Citation: P. Denheijer et al., EVALUATION OF A WEIGHT-ADJUSTED SINGLE-BOLUS PLASMINOGEN-ACTIVATOR INPATIENTS WITH MYOCARDIAL-INFARCTION - A DOUBLE-BLIND, RANDOMIZED ANGIOGRAPHIC TRIAL OF LANOTEPLASE VERSUS ALTEPLASE, Circulation, 98(20), 1998, pp. 2117-2125

Authors: JERNBERG T ISAKSSON A LINDAHL B WALLENTIN L
Citation: T. Jernberg et al., PROGNOSTIC IMPORTANCE OF TROPONIN-T AND CONTINUOUS 12-LEAD ICHEMIA-MONITORIG WITH THE ST-GUARD SYSTEM, Circulation, 98(17), 1998, pp. 2232-2232

Authors: FROSTFELDT G SWAHN E WALLENTIN L SIEGBAHN A
Citation: G. Frostfeldt et al., INFLUENCE ON COAGULATION ACTIVITY BY SUBCUTANEOUS LMW HEPARIN AS AN ADJUVANT TO THROMBOLYSIS IN ACUTE MYOCARDIAL-INFARCTION, Circulation, 98(17), 1998, pp. 4104-4104

Authors: KARASON K WALLENTIN L LARSSON B SJOSTROM L
Citation: K. Karason et al., EFFECTS OF OBESITY AND WEIGHT-LOSS ON LEFT-VENTRICULAR MASS AND RELATIVE WALL THICKNESS - SURVEY AND INTERVENTION STUDY, BMJ. British medical journal, 315(7113), 1997, pp. 912-916

Authors: SAETRE H LINDAHL B WALLENTIN L
Citation: H. Saetre et al., REDUCTION OF MYOCARDIAL DAMAGE BY PROLONGED TREATMENT WITH SC LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) IN UNSTABLE CAD, Journal of the American College of Cardiology, 29(2), 1997, pp. 7606-7606

Authors: LINDAHL B VENGE P WALLENTIN L
Citation: B. Lindahl et al., TROPONIN-T IDENTIFIES PATIENTS WITH UNSTABLE CORONARY-ARTERY DISEASE WHO BENEFIT FROM LONG-TERM ANTITHROMBOTIC PROTECTION, Journal of the American College of Cardiology, 29(1), 1997, pp. 43-48

Authors: TOSS H WALLENTIN L SIEGBAHN A
Citation: H. Toss et al., SIGNS OF INCREASED FIBRINOLYSIS DURING LOW-MOLECULAR-WEIGHT HEPARIN TREATMENT IN UNSTABLE CORONARY-ARTERY DISEASE, Thrombosis and haemostasis, 1997, pp. 1174-1174

Authors: SIEGBAHN A ERNOFSSON I STREKERUND F TOSS H ABILDGAARD U WALLENTIN L
Citation: A. Siegbahn et al., LOW-MOLECULAR-WEIGHT HEPARIN REDUCES THROMBIN GENERATION AND ACTIVITYIN UNSTABLE CORONARY-ARTERY DISEASE, Thrombosis and haemostasis, 1997, pp. 1175-1175

Authors: TOSS H SIEGBAHN A WALLENTIN L
Citation: H. Toss et al., FACTOR XA INHIBITION, EFFICACY AND BLEEDING TENDENCY ARE INFLUENCED BY GENDER AND SMOKING IN LOW-MOLECULAR HEPARIN TREATED UNSTABLE CORONARY-ARTERY DISEASE, Thrombosis and haemostasis, 1997, pp. 1183-1183

Authors: OLDGREN J GRIP L SIEGBAHN A WALLENTIN L
Citation: J. Oldgren et al., REACTIVATION AFTER CESSATION OF THROMBIN INHIBITION IN UNSTABLE CORONARY-ARTERY DISEASE OCCURS REGARDLESS OF ASPIRIN DOSE, Thrombosis and haemostasis, 1997, pp. 2016-2016

Authors: LINDER R OLDGREN J EGBERG N GRIP L LARSON G SIEGBAHN A WALLENTIN L
Citation: R. Linder et al., INOGATRAN INHIBITS THROMBIN GENERATION AND FIBRIN TURNOVER MORE EFFECTIVELY THAN HEPARIN IN PATIENTS WITH UNSTABLE CORONARY-ARTERY DISEASE, Thrombosis and haemostasis, 1997, pp. 2390-2390

Authors: GRIP L FRISON L WALLENTIN L DELLBORG M GRANDE P HALINEN M HELD P MYHRE E RYDEN L SWAHN E SWEDBERG K THYGESEN K SLEIGHT P WILHELMSEN L NASLUND U GUNDERSEN T FISCHERHANSEN J LEHTO S BARRET M NILSSON JE TEGERNILSSON AC THORSEN M ANDERSEN F LUNDSTROM M HILDEBRAND A DEFLONOLSSON C FORSBY M ISBERG P LARSSON C NORGAARD B RASMUSSEN S VIDEBAEK J KLARLUND K LANDORPH A NIELSEN T AGNER E HOJGAARD MV HELQVIST S RASMUSSEN SL EGSTRUP K MYGIND L HANSEN JF SAJADIEH A GILL S HAGHFELT T MARKENVARD J THOMASSEN A JENSEN N PETERSEN J JENSEN G FISCHER T SIPILA R KIILAVUORI K HAMALAINEN L NURMINEN J MELIN J KOSKELA E HURME H VAUHONEN I HONKANEN T UTRIANEN S HAMALAINEN T LILJA M UKKOLVA O KIVELA H SODERSTROM S POHJOLASINTONEN S HUSSI E LARSEN A FALANG JE SCHARTUMHANSEN H PAULSEN A OMLAND T HOLM T EDVARDSEN T THYBO NK HAEREM J KAPELRUD H WAAGE K ROSSEBO B HAFSOY K HAMMARSTROM E ASTROM L HALL E WETTERVIK C FORSBERG SA TYGESEN H FREDRIKSSON B EKDAHL S KIHLSTROM K MAGNUSSON JO STJERNA A MARU F NILSSON H AKRAWI S SAETRE H AHLMARK G AHLBERG G LINDE B HAGSTROM L GUSTAFSSON G GUSTAVSSON PE LARSSON AC ANDERSEN K RUTER G KIERKEGAARD A HARDHAMMAR P KARLSSON JE SVENSSON O LANDGREN F HOLMBERG B RYDEN S WEINER L DANIELEWICZ M MALMROS B NICOL P JANZON M OHLIN H HANSEN O TINGBERG E NYMAN I FJELSTAD B AHLSTROM P HEDBACK B PERK J SVENNBERG L ELLSTROM J BOMAN K REMMETS J KRISTENSSON BE LINDER R HULTING J HOIJER J MOLLER BH LYCKSELL M WAHLIN M SANDSTEDT L REDFORS A BORRETZEN J OSTBERG G JOHANSSON B MORNER S LINDAHL B OLDGREN J JONSSON J NEMECZE K THORSEN S JOHANSSON PA SINNERSTAD B LARSSON LE BAND S MARSELL R
Citation: L. Grip et al., A LOW-MOLECULAR-WEIGHT, SELECTIVE THROMBIN INHIBITOR, INOGATRAN, VS HEPARIN, IN UNSTABLE CORONARY-ARTERY DISEASE IN 1209 PATIENTS - A DOUBLE-BLIND, RANDOMIZED, DOSE-FINDING STUDY, European heart journal, 18(9), 1997, pp. 1416-1425

Authors: LINDAHL B ANDREN B OHLSSON J VENGE P WALLENTIN L LUNDIN L TOSS H LINDAHL B LINDSTROM G SVENSSON E ALSJO G SLTRE H AHLBERG G HAGSTROM L SUNDQVIST C PIHL E GUSTAFSSON G LARSSON L GUSTAVSSON PE LOFMARK R LUNDQVIST IB HAMMARSTROM E BASTANI H ENG E LUNDIN P REHNQVIST N AMBRANT B OBLACK P HOLMSTRAND M FJELSTAD B ARONSON D OSTBERG S FRISELL JE HEDMAN A SANDSTROM M PERERS G IRVING P ANDERSSON I HULTING J HOJIER J AMANULLAH A SAMAD B STEINBRUCK I EKBLOM M SWAHN E KARLSSON E NIELSEN N SAFSTROM K LOGANDER E FALK SA FRIDEN J NILSSON O RONNHAGEN K ABOUZEID L HEDBACK B PERK J OSSIANSSONPETTERSSON L HOLMBERG B LANDGREN F RYDEN S BJURLING E KARLSSON JE MALMBERG C SVENSSON O SVENSSON E EKDAHL S NYMAN I PANTZAR Y ENGHOFF E LUNDSTROM T ANDREN B OHLSSON J WALLENTIN L OHLSSON J LINDSTROM G LOGANDER E SVENSSON E
Citation: B. Lindahl et al., RISK STRATIFICATION IN UNSTABLE CORONARY-ARTERY DISEASE - ADDITIVE VALUE OF TROPONIN-T DETERMINATIONS AND PREDISCHARGE EXERCISE TESTS, European heart journal, 18(5), 1997, pp. 762-770

Authors: ELLENIUS J GROTH T LINDAHL B WALLENTIN L
Citation: J. Ellenius et al., EARLY ASSESSMENT OF PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION BY BIOCHEMICAL MONITORING AND NEURAL-NETWORK ANALYSIS, Clinical chemistry, 43(10), 1997, pp. 1919-1925

Authors: TOSS H LINDAHL B SIEGBAHN A WALLENTIN L
Citation: H. Toss et al., PROGNOSTIC INFLUENCE OF INCREASED FIBRINOGEN AND C-REACTIVE PROTEIN-LEVELS IN UNSTABLE CORONARY-ARTERY DISEASE, Circulation, 96(12), 1997, pp. 4204-4210

Authors: WALLENTIN L
Citation: L. Wallentin, UNSTABLE CORONARY-ARTERY DISEASE - NEED FOR LONG-TERM ANTITHROMBOTIC TREATMENT - ASPIRIN ALONE IS NOT SUFFICIENT, I WOULD ASSOCIATE AN ANTICOAGULANT, Cardiovascular Research, 33(2), 1997, pp. 292-294

Authors: TURPIE AGG WALLENTIN L
Citation: Agg. Turpie et L. Wallentin, A SYMPOSIUM - NEW FRONTIERS IN THE MANAGEMENT OF UNSTABLE CORONARY-ARTERY DISEASE - INTRODUCTION, The American journal of cardiology, 80, 1997, pp. 1-1

Authors: SWAHN E WALLENTIN L
Citation: E. Swahn et L. Wallentin, LOW-MOLECULAR-WEIGHT HEPARIN (FRAGMIN) DURING INSTABILITY IN CORONARY-ARTERY DISEASE (FRISC), The American journal of cardiology, 80, 1997, pp. 25-29

Authors: LINDAHL B ANDREN B OHLSSON J VENGE P WALLENTIN L
Citation: B. Lindahl et al., NONINVASIVE RISK STRATIFICATION IN UNSTABLE CORONARY-ARTERY DISEASE -EXERCISE TEST AND BIOCHEMICAL MARKERS, The American journal of cardiology, 80, 1997, pp. 40-44

Authors: WALLENTIN L HUSTED S KONTNY F SWAHN E
Citation: L. Wallentin et al., LONG-TERM LOW-MOLECULAR-WEIGHT HEPARIN (FRAGMIN) AND OR EARLY REVASCULARIZATION DURING INSTABILITY IN CORONARY-ARTERY DISEASE (THE FRISC-IISTUDY)/, The American journal of cardiology, 80, 1997, pp. 61-63
Risultati: 1-25 | 26-49